Search

everythinglearnresearchcommunity

for

Search:↓

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Spironolactone may help reduce hair loss in androgenic alopecia.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

PCOS is linked to low-grade chronic inflammation.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Detailed history and physical examination are crucial for diagnosing hair loss.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Androgenetic alopecia in women needs more research and better management strategies.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Japanese women typically start experiencing hair loss after 40, with reduced hair density and thickness being the main factors.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

More research is needed to determine if iron deficiency causes hair loss.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.